Mia Lundblad-arkiv - BioStock

New acting CEO in Arcede Pharma

Arcede Pharma appoints acting CEO

21 December, 2023

Toleranzia stegar på

Arcede proceeds to stability study in collaboration with Iconovo

20 November, 2023

Arcede Pharma och Iconovo

Arcede Pharma and Iconovo receive funding from Swelife

4 April, 2023

Arcede Pharma släpper sin Q3-rapport

Arcede Pharma looks ahead with strengthened team

15 February, 2023

Arcede Pharma is preparing for clinical studies

Arcede Pharma prepares for clinical studies

7 December, 2022

Arcede Pharmas toxicological study shows RCD405 is well tolerated

Arcede Pharma’s RCD405 well tolerated

28 November, 2022

ArcedePharma_MiaLundblad_BioStockInvestorMeeting

BioStock Investor Meeting: Arcede Pharma presents

22 September, 2022

BioStock Investor Meeting, September 14

15 August, 2022